Locally Advanced Pancreatic Cancer
Oncology
2
Pipeline Programs
4
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
OncoSil MedicalAustralia - Macquarie Park
1 program1
FOLFIRINOX chemotherapyPhase 21 trial
Active Trials
Heidelberg PharmaGermany - Ladenburg
1 programCarbon Ion RadiotherapyN/A1 trial
Active Trials
NCT01795274Withdrawn0
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
RenovoRxGemcitabine
OncoSil MedicalFOLFIRINOX chemotherapy
Clinical Trials (3)
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
Start: Mar 2018Est. completion: Sep 2026
Phase 3Recruiting
FOLFIRINOX Versus OncoSil™ in Addition to FOLFIRINOX in Patients With Locally Advanced Pancreatic Adenocarcinoma
Start: Apr 2023Est. completion: Jul 2027
Phase 2Active Not Recruiting
Phase I Study Evaluating the Treatment of Patients With Locally Advanced Pancreatic Cancer With Carbon Ion Radiotherapy: The PHOENIX-01 Trial
0
N/AWithdrawn
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
5m ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
5m ago
Office Administrator
SystImmune
5m ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
15m ago
Working Student Office Management Support (m/f/d)
Mindpeak
Hamburg
19m ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
19m ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
1 actively recruiting trials
4 companies competing in this space